Effect of psychopharmacotherapy on suicide risk in psychiatric inpatients.
A retrospective analysis of the psychopharmacotherapy of 25 inpatients who had committed suicide and the same number of matched control subjects was carried out comparing the quality and doses of medication. Two statistically significant differences between the groups considering the medication were found. The suicide group had lower neuroleptic doses and they more often used benzodiazepine medication than the control group. The presence of depression was documented in the hospital charts more frequently in the suicides, but no differences were observed between the groups in the amount of antidepressant medication used.
Taiminen
T J
TJ
Department of Psychiatry, University of Turku, Finland.
D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines; D005260:Female; D006778:Hospitals, Psychiatric; D006801:Humans; D007297:Inpatients / Q000523:psychology*; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012189:Retrospective Studies; D012307:Risk Factors; D013405:Suicide / Q000706:statistics & numerical data*
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D011619:Psychotropic Drugs; D001569:Benzodiazepines